GRACE评分、TIMI评分联合NT-proBNP对急性心肌梗死患者预后的预测作用
GRACE Score and TIMI Score Combined with NT-proBNP on Predicting the Prognosis of Patients with Acute Myocardial Infarction
摘要: 目的:研究目前被广泛推荐的风险评分与心血管生物标志物的组合是否可以更好地预测急性心肌梗死患者的主要心血管不良事件(MACE)的发生。方法:所有入选患者均为2018年10月至2019年10月在青岛大学附属医院急诊科连续治疗,并确诊为急性心肌梗死的患者,对这些纳入患者进行回顾性调查。入院后收集病史、化验多项生化指标及计算风险评分,结局为主要心脏不良事件(MACE)。对患者进行随访,记录并评估MACE的发生率。根据是否发生MACE将患者分为事件组和非事件组,比较基线资料之间的差异,并采用Cox回归评价MACE的独立显著危险因素。绘制接收者操作特性曲线(ROC曲线),并通过计算ROC曲线下面积(AUC)比较风险评分及其与其他生物标志物联合的预测价值。结果:纳入的399例患者中,MACE发生率为24.6% (n = 98)。通过Cox回归分析可以得出,Ln (NT-proBNP)、GRACE评分和TIMI评分均为MACE的独立预测因素。根据ROC分析Ln (NT-proBNP) (AUC, 0.790; 95% CI, 0.738~0.843; P < 0.001),GRACE评分(AUC, 0.801; 95% CI, 0.749~0.853; P < 0.001)和TIMI评分(AUC, 0.743; 95% CI, 0.688~0.799; P < 0.001)在预测MACE方面均表现出良好的性能。此外,联合使用时ROC曲线下面积(AUC)显著增加(AUC, 0.854; 95 %CI, 0.824~0.901; P < 0.001)。结论:GRACE和TIMI这两种广泛应用的风险评分在MACE的发生上均有较好的预测能力。而它们与NT-proBNP的联合使用增加了预测的准确性。
Abstract: Aim: To investigate whether the combination of widely recommended risk scores with cardiovascular biomarkers could better predict MACE occurrence in patients with acute myocardial infarction. Methods: Patients diagnosed with acute myocardial infarction who consecutively treated at the Emergency Department of the Affiliated Hospital of Qingdao University from October 2018 to October 2019 were enrolled. Retrospective study was performed among these enrolled patients. The outcome was major adverse cardiac events (MACE). Medical history, multiple laboratory biomarkers and risk scores were collected and calculated after admission. Patients were followed up and the incidence of MACE was assessed. The patients were divided into event group and non-event group according to whether MACE occurred or not, and the differences between baseline data were compared. Cox proportional hazards regression was used to evaluate the independent significant risk factors for MACE. Receiver operating curve (ROC) analysis was performed to analyze the predictive value. Risk scores and their predictive values in combination with other biomarkers were compared by calculating area under receiver operating characteristic curves (AUCs). Results: Among the 399 patients included, the incidence of MACE was 24.6% (n = 98). According to Cox proportional hazards regression analysis, Ln (NT-proBNP), GRACE scoreand TIMI score were all independent predictors of MACE. And according to receiver operating characteristic analysis, Ln (NT-proBNP) (AUC, 0.790; 95% CI, 0.738~0.843; P < 0.001), GRACE score (AUC, 0.801; 95% CI, 0.749~0.853; P < 0.001) and TIMI score (AUC, 0.743; 95% CI, 0.688~0.799; P < 0.001) all exhibited good performance on predicting MACE. In addition, the area under the ROC curve (AUC) increased significantly when they were used in combination (AUC, 0.854; 95% CI, 0.824~0.901; P < 0.001). Conclusions: The current risk scores: GRACE and TIMI all have good predictive value for the occurrence of MACE. While their combined use and combination with NT-proBNP increased the accuracy of the prediction.
文章引用:金睿杰, 任雪萌, 姬赞赞, 李鹏. GRACE评分、TIMI评分联合NT-proBNP对急性心肌梗死患者预后的预测作用[J]. 临床医学进展, 2021, 11(11): 5213-5223. https://doi.org/10.12677/ACM.2021.1111770

参考文献

[1] Nichols, M., Townsend, N., Scarborough, P. and Rayner, M. (2014) Cardiovascular Disease in Europe 2014: Epidemiological Update. European Heart Journal, 35, 2950-2959. [Google Scholar] [CrossRef] [PubMed]
[2] Benjamin, E.J., et al. (2018) Heart Disease and Stroke Statistics—2018 Update: A Report from the American Heart Association. Circulation, 137, e467-e492. [Google Scholar] [CrossRef
[3] Reed, G.W., Rossi, J.E. and Cannon, C.P. (2017) Acute Myocardial Infarction. The Lancet, 389, 197-210. [Google Scholar] [CrossRef
[4] Thygesen, K., et al. (2012) Third Universal Definition of Myocardial Infarction. European Heart Journal, 33, 2551-2567. [Google Scholar] [CrossRef] [PubMed]
[5] Thygesen, K., et al. (2018) Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology, 72, 2231-2264. [Google Scholar] [CrossRef] [PubMed]
[6] Shen, C. and Ge, J. (2018) Epidemic of Cardiovascular Disease in China: Current Perspective and Prospects for the Future. Circulation, 138, 342-344. [Google Scholar] [CrossRef
[7] Granger, C.B., et al. (2003) Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events. Archives of Internal Medicine, 163, 2345-2353. [Google Scholar] [CrossRef] [PubMed]
[8] Lin, A., Devlin, G., Lee, M. and Kerr, A.J. (2014) Performance of the GRACE Scores in a New Zealand Acute Coronary Syndrome Cohort. Heart, 100, 1960-1966. [Google Scholar] [CrossRef] [PubMed]
[9] Shuvy, M., et al. (2018) Accuracy of the Global Registry of Acute Coronary Events (GRACE) Risk Score in Contemporary Treatment of Patients with Acute Coronary Syndrome. The Canadian Journal of Cardiology, 34, 1613-1617. [Google Scholar] [CrossRef] [PubMed]
[10] Morrow, D.A., et al. (2000) TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarction Myocardium Early II Trial Substudy. Circulation, 102, 2031-2037. [Google Scholar] [CrossRef
[11] Antman, E.M., et al. (2000) The TIMI Risk Score for Unstable Angina/Non-ST Elevation MI: A Method for Prognostication and Therapeutic Decision Making. JAMA, 284, 835-842. [Google Scholar] [CrossRef] [PubMed]
[12] Morrow, D.A., et al. (2001) Application of the TIMI Risk Score for ST-Elevation MI in the National Registry of Myocardial Infarction 3. JAMA, 286, 1356-1359. [Google Scholar] [CrossRef] [PubMed]
[13] Bradshaw, P.J., et al. (2007) Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Index for Predicting Early Mortality in a Population-Based Cohort of STEMI and Non-STEMI Patients. The Canadian Journal of Cardiology, 23, 51-56. [Google Scholar] [CrossRef
[14] Bibbins-Domingo, K., Ansari, M., Schiller, N.B., Massie, B. and Whooley, M.A. (2003) B-Type Natriuretic Peptide and Ischemia in Patients with Stable Coronary Disease: Data from the Heart and Soul Study. Circulation, 108, 2987-2992. [Google Scholar] [CrossRef
[15] Kragelund, C., et al. (2005) N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease. The New England Journal of Medicine, 352, 666-675. [Google Scholar] [CrossRef
[16] Gong, P., et al. (2016) Plasma D-Dimer as a Useful Marker Predicts Severity of Atherosclerotic Lesion and Short-Term Outcome in Patients with Coronary Artery Disease. Clinical and Applied Thrombosis/Hemostasis, 22, 633-640. [Google Scholar] [CrossRef] [PubMed]
[17] Tataru, M.C., Heinrich, J., Junker, R., Schulte, H., von Eckardstein, A., Assmann, G. and Koehler, E. (1999) D-Dimers in Relation to the Severity of Arteriosclerosis in Patients with Stable Angina Pectoris after Myocardial Infarction. European Heart Journal, 20, 1493-1502. [Google Scholar] [CrossRef] [PubMed]
[18] Kikkert, W.J., et al. (2014) D-Dimer Levels Predict Ischemic and Hemorrhagic Outcomes after Acute Myocardial Infarction: A HORIZONS-AMI Biomarker Substudy. Journal of Thrombosis and Thrombolysis, 37, 155-164. [Google Scholar] [CrossRef] [PubMed]
[19] Tahhan, A.S., et al. (2018) High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes. Journal of the American Heart Association, 7, e007914. [Google Scholar] [CrossRef
[20] Clerico, A., Emdin, M. and Passino, C. (2014) Cardiac Biomarkers and Risk Assessment in Patients Undergoing Major Non-Cardiac Surgery: Time to Revise the Guidelines? Clinical Chemistry and Laboratory Medicine, 52, 959-963. [Google Scholar] [CrossRef] [PubMed]
[21] Omland, T., et al. (2013) Prognostic Value of Cardiac Troponin I Measured with a Highly Sensitive Assay in Patients with Stable Coronary Artery Disease. Journal of the American College of Cardiology, 61, 1240-1249. [Google Scholar] [CrossRef] [PubMed]
[22] Prugger, C., et al. (2013) Multiple Biomarkers for the Prediction of Ischemic Stroke: The PRIME Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 659-666. [Google Scholar] [CrossRef
[23] Ibanez, B., et al. (2018) 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation: The Task Force for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal, 39, 119-177. [Google Scholar] [CrossRef] [PubMed]
[24] Roffi, M., et al. (2016) 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal, 37, 267-315. [Google Scholar] [CrossRef] [PubMed]
[25] Huang, W., et al. (2016) Performance of the GRACE Risk Score 2.0 Simplified Algorithm for Predicting 1-Year Death after Hospitalization for an Acute Coronary Syndrome in a Contemporary Multiracial Cohort. American Journal of Cardiology, 118, 1105-1110. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, S., et al. (2019) Burden of Cardiovascular Diseases in China, 1990-2016: Findings from the 2016 Global Burden of Disease Study. JAMA Cardiology, 4, 342-352. [Google Scholar] [CrossRef] [PubMed]
[27] Leong, D.P., et al. (2017) Reducing the Global Burden of Cardiovascular Disease, Part 2: Prevention and Treatment of Cardiovascular Disease. Circulation Research, 121, 695-710. [Google Scholar] [CrossRef
[28] Laslett, L.J., et al. (2012) The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues: A Report from the American College of Cardiology. Journal of the American College of Cardiology, 60, S1-S49. [Google Scholar] [CrossRef] [PubMed]
[29] Chen, Y.H., Huang, S.S. and Lin, S.J. (2018) TIMI and GRACE Risk Scores Predict Both Short-Term and Long-Term Outcomes in Chinese Patients with Acute Myocardial Infarction. Acta Cardiologica Sinica, 34, 4-12.
[30] Gray, H.H. and Henderson, R.A. (2011) The GRACE Score’s Performance in Predicting In-Hospital and 1-Year Outcome. Heart, 97, 1461-1462. [Google Scholar] [CrossRef] [PubMed]
[31] Ramsay, G., Podogrodzka, M., McClure, C. and Fox, K.A.A. (2007) Risk Prediction in Patients Presenting with Suspected Cardiac Pain: The GRACE and TIMI Risk Scores versus Clinical Evaluation. QJM, 100, 11-18. [Google Scholar] [CrossRef] [PubMed]
[32] Lowe, G.D., et al. (2004) C-Reactive Protein, Fibrin D-Dimer, and Risk of Ischemic Heart Disease: The Caerphilly and Speedwell Studies. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 1957-1962. [Google Scholar] [CrossRef
[33] Schiele, F., et al. (2010) C-Reactive Protein Improves Risk Prediction in Patients with Acute Coronary Syndromes. European Heart Journal, 31, 290-297. [Google Scholar] [CrossRef] [PubMed]
[34] Eggers, K.M., et al. (2008) Prevalence and Pathophysiological Mechanisms of Elevated Cardiac Troponin I Levels in a Population-Based Sample of Elderly Subjects. European Heart Journal, 29, 2252-2258. [Google Scholar] [CrossRef] [PubMed]
[35] Khan, S.Q., et al. (2009) N-Terminal Pro-B-Type Natriuretic Peptide Complements the GRACE Risk Score in Predicting Early and Late Mortality Following Acute Coronary Syndrome. Clinical Science (London, England: 1979), 117, 31-39. [Google Scholar] [CrossRef